Severe Sepsis Management Are We Doing Enough?

Ahrens, Tom; Vollman, Kathleen
October 2003
Critical Care Nurse;Oct2003 Supplement, Vol. 24, p2
Academic Journal
Addresses issues concerning the treatment and management of severe sepsis in the critical care setting. Barriers to the use of Xigris as treatment for severe sepsis; Incidence and pathophysiology; Tissue perfusion and oxygen delivery in sever sepsis; Signs and symptoms; Treatment options. INSETS: CASE STUDY 1;CASE STUDY 2.


Related Articles

  • Eritoran: the evidence of its therapeutic potential in sepsis. Raja, Shahzad G.; Dreyfus, Gilles D. // Core Evidence;2007, Vol. 2 Issue 3, p199 

    Introduction: Sepsis and its sequelae are the leading causes of morbidity and mortality in critically ill patients. The burden to healthcare economies is also considerable. As the pathophysiology of sepsis is better defined, interventions aiming to treat sepsis are emerging. Eritoran (E5564), a...

  • Sepsis and the heart. Hunter, J. D.; Doddi, M. // BJA: The British Journal of Anaesthesia;Jan2010, Vol. 104 Issue 1, p3 

    Septic shock, the most severe complication of sepsis, accounts for ∼10% of all admissions to intensive care. Our understanding of its complex pathophysiology remains incomplete but clearly involves stimulation of the immune system with subsequent inflammation and microvascular dysfunction....

  • Clinical sepsis and septic shock—definition, diagnosis and management principles. Vincent, Jean-Louis // Langenbeck's Archives of Surgery;Nov2008, Vol. 393 Issue 6, p817 

    Sepsis remains a common problem in critically ill patients. Considerable advances have been made in our understanding of the pathophysiology of sepsis and recent years have seen a surge of potential new therapeutic agents for sepsis. Definitions have been rethought and strategies proposed to...

  • CITATIONS AND CLINICIANS' NOTES: INTENSIVE CARE.  // Current Medical Literature: Respiratory Medicine;2004, Vol. 18 Issue 3, p74 

    The article presents information on different aspects of intensive care. Non-invasive positive-pressure ventilation (NIV) is increasingly recognized as beneficial in a variety of clinical settings. Sepsis is the most common cause of death in patients who require intensive care. Around 40 percent...

  • Evaluation and management of decompression illness--an intensivist's perspective. Tetzlaff, Kay; Shank, Erik S.; Muth, Claus M. // Intensive Care Medicine;Dec2003, Vol. 29 Issue 12, p2128 

    Decompression illness (DCI) is becoming more prevalent as more people engage in activities involving extreme pressure environments such as recreational scuba-diving. Rapid diagnosis and treatment offer these patients the best chance of survival with minimal sequelae. It is thus important that...

  • Propofol infusion syndrome: Case report and literature review. Orsini, Jose; Nadkarni, Abhijeet; Chen, Julie; Cohen, Nina // American Journal of Health-System Pharmacy;5/15/2009, Vol. 66 Issue 10, p908 

    Purpose. A case of propofol infusion syndrome in a patient with respiratory failure and sepsis is reported. Summary. A 36-year-old Hispanic woman was admitted to the medical intensive care unit for treatment of respiratory failure and sepsis, likely secondary to pneumonia. Her medical history...

  • Prevention of Lymphocyte Apoptosis -- A Potential Treatment of Sepsis? Hotchkiss, Richard S.; Coopersmith, Craig M.; Karl, Irene E. // Clinical Infectious Diseases;11/15/2005 Supplement, Vol. 41, pS465 

    Sepsis is the leading cause of death in surgical intensive care units and is a major cause of morbidity and mortality in neonatal and medical intensive care units. The Centers for Disease Control and Prevention estimates that, in the United States alone, ∼500,000 people develop sepsis and...

  • A role for plasma removal during sepsis? Grooteman, M. P. C.; Groeneveld, A. B. J. // Intensive Care Medicine;May2000, Vol. 26 Issue 5, p493 

    Comments on the potential of blood purification techniques as a treatment option for severe sepsis. Role of pro-inflammatory mediators in hemodynamic abnormalities and multiple organ failure; Removal of pro-inflammatory mediators by both filtration and adsorption to the filter membrane; Effect...

  • Expert's comments. Mani, R. K. // Indian Journal of Critical Care Medicine;Jan-Mar2010, Vol. 14 Issue 1, p39 

    In this article the comments of the experts on the "Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients" is presented. It states that there is no clear evidence on the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics